SYROS PHARMACEUTICALS, INC. Lessee, Operating Lease, Liability, to be Paid
SYROS PHARMACEUTICALS, INC. had Lessee, Operating Lease, Liability, to be Paid of $26.67 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2024-05-14
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid $26.67M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid $27.71M.
- 2023-09-30: Lessee, Operating Lease, Liability, to be Paid $28.74M.
- 2023-06-30: Lessee, Operating Lease, Liability, to be Paid $29.74M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2024-03-31 | $26.67M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $27.71M 10-K · filed 2024-03-27 |
| 2023-09-30 | $28.74M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $29.74M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $30.75M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $31.76M 10-K · filed 2023-03-02 |
| 2022-09-30 | $32.76M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $33.73M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $34.71M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $35.69M 10-K · filed 2022-03-15 |
| 2021-09-30 | $36.66M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $37.61M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $38.57M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $39.52M 10-K · filed 2021-03-04 |
| 2020-09-30 | $40.46M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $41.38M 10-Q · filed 2020-08-06 |